RevitaDERM PSORIASIS

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: RevitaDERM PSORIASIS
Generic name: COAL TAR
Manufacturer: Blaine Labs Inc.
Product type: HUMAN OTC DRUG
SPL set ID: 06ad14d3-4ff4-4283-8197-8626aad3b8d0
SPL ID: 52aacff7-6265-4446-9dd0-dfef99dd4785
Version: 4
Effective date: 2023-12-21
Source export date: 2026-09-28
Source partition: 1
Source file: https://download.open.fda.gov/drug/label/drug-label-0001-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-09-28/9c7783846d422acb0c9e59457606951c785a7d28cc631c8cc4839d0dc7c55f39/drug-label-0001-of-0014.json.zip
Source manifest SHA-256: cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run: 20260929T050834Z
Imported at: 2026-09-29 05:14:04

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 12 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M032	openfda.application_number
brand name		RevitaDERM PSORIASIS	openfda.brand_name
generic name		COAL TAR	openfda.generic_name
manufacturer name		Blaine Labs Inc.	openfda.manufacturer_name
ndc	package	63347-112-01	openfda.package_ndc
ndc	product	63347-112	openfda.product_ndc
ndc11	package	63347011201	derived:openfda.package_ndc
rxcui		317080	openfda.rxcui
rxcui		1297944	openfda.rxcui
spl id		52aacff7-6265-4446-9dd0-dfef99dd4785	id
spl set id		06ad14d3-4ff4-4283-8197-8626aad3b8d0	set_id
unii		R533ESO2EC	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings Section Warnings For external use only. Ask a doctor before use For prolonged periods If condition covers a large area of the body Around the rectum or in the genital area or groin With other forms of psoriasis therapy such as ultraviolet radiation or prescription drugs.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.